phosphatidylcholines has been researched along with paclitaxel in 40 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (paclitaxel) | Trials (paclitaxel) | Recent Studies (post-2010) (paclitaxel) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 31,874 | 5,729 | 15,395 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (5.00) | 18.2507 |
| 2000's | 15 (37.50) | 29.6817 |
| 2010's | 20 (50.00) | 24.3611 |
| 2020's | 3 (7.50) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, A; Straubinger, RM | 1 |
| Chelvi, TP; Kaur, J; Ralhan, R; Sharma, D | 1 |
| Ali, S; Janoff, A; Mayhew, E; Minchey, S | 1 |
| Arpicco, S; Brusa, P; Cattel, L; Ceruti, M; Crosasso, P; Dosio, F | 1 |
| Adamo, S; Coletti, D; Molinaro, M; Naro, F; Palleschi, S; Silvestroni, L | 1 |
| Caputo, O; Cavalli, R; Gasco, MR | 1 |
| Borst, P; Sarkadi, B; Smith, AJ; Szabo, K; Szakacs, G; van Helvoort, A; van Meer, G; Varadi, A; Welker, E | 1 |
| Adamo, S; Coletti, D; Molinaro, M; Palleschi, S; Silvestroni, L; Tomei, F | 1 |
| Berman, E; Cohen, JS; Mardor, Y; Ringel, I; Sterin, M | 1 |
| Chakilam, AR; Gao, Z; Lukyanov, AN; Torchilin, VP | 1 |
| Allen, C; Ho, EA; Piquette-Miller, M; Vassileva, V | 1 |
| Allen, C; Blicker, M; Grant, J; Piquette-Miller, M | 1 |
| Arica Yegin, B; Benoît, JP; Lamprecht, A | 1 |
| Allen, C; De Souza, R; Grant, J; Piquette-Miller, M; Vassileva, V | 1 |
| Choi, MK; Chung, SJ; Cui, FD; Kim, DD; Lin, H; Shim, CK; Yang, T | 1 |
| Lacko, AG; McConathy, WJ; Mooberry, L; Nair, MP; Paranjape, S | 1 |
| Chen, CA; Hsiao, SM; Hsieh, CY; Lin, HH; Wei, LH | 1 |
| Li, J; Wei, YM; Ye, Y; Zhao, L | 1 |
| Jain, S; Khandhuja, KL; Tiwary, AK; Utreja, P; Yadav, S | 1 |
| Chen, H; Chen, J; Fang, L; Gao, X; Gu, G; Hu, Q; Jiang, M; Liu, Z; Pang, Z; Song, Q; Xia, H; Zeng, N | 1 |
| Cai, L; Chen, L; Chen, X; Duan, X; Li, X; Qian, Z; Qiu, N; Wang, W; Wang, X; Wei, Y; Wen, J; Yang, L | 1 |
| Khemapech, N; Lertkhachonsuk, R; Oranratanaphan, S; Termrungruanglert, W; Vasurattana, A | 1 |
| Allen, C; Grant, J; Tsallas, A; Zahedi, P | 1 |
| Cui, Y; Li, L; Li, Y; Zhao, Y | 1 |
| Meng, H; Xu, Y | 1 |
| Burgett, AW; Kothapalli, NR; Liu, R; Pan, N; Rao, W; Yang, Z | 1 |
| Kang, M; Loverde, SM | 1 |
| Hong, SS; Kim, SH; Lim, SJ | 1 |
| England, CG; Frieboes, HB; Kuttan, A; Miller, MC; Trent, JO | 1 |
| Guo, QT; Shi, YJ; Zhang, XF | 1 |
| Ahmed, W; Albed Alhnan, M; Elhissi, A; Jain, M; Najlah, M; Phoenix, DA; Taylor, KMG; Wan, KW | 1 |
| Liu, Y; Mu, S; Olerile, LD; Selotlegeng, L; Wang, T; Zhang, B; Zhang, J; Zhang, N | 1 |
| Fukuoka, Y; Higaki, K; Kimura, T; Ogawara, KI; Yoshizawa, Y | 1 |
| Fan, Z; Guo, F; Hou, Z; Lai, K; Li, Y; Shang, J; Su, G; Zhao, H | 1 |
| Akhberdi, O; Chen, L; Li, Y; Wang, D; Wang, H; Wei, D; Yu, X; Zhang, Q; Zhu, X | 1 |
| Ingle, SG; Monpara, JD; Pai, RV; Vavia, PR | 1 |
| Cai, C; Chu, X; Han, J; Liu, M; Pei, W; Wang, Z; Zhang, H; Zhao, Y | 1 |
| Narayanaswamy, R; Torchilin, VP | 1 |
| Ewert, KK; Fisher, WS; Li, Y; Safinya, CR; Steffes, VM; Zhen, Y | 1 |
| Dutta, P; Pramanik, D; Singh, JK | 1 |
1 trial(s) available for phosphatidylcholines and paclitaxel
| Article | Year |
|---|---|
Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubicin; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Phosphatidylcholines; Polyethylene Glycols | 2009 |
39 other study(ies) available for phosphatidylcholines and paclitaxel
| Article | Year |
|---|---|
Novel taxol formulations: preparation and characterization of taxol-containing liposomes.
Topics: Animals; Cell Division; Cell Line; Drug Carriers; Drug Stability; Drug Storage; Electrochemistry; Female; Glycerol; Humans; Liposomes; Mice; Mice, Inbred BALB C; Paclitaxel; Pharmaceutical Vehicles; Phosphatidylcholines; Phosphatidylglycerols | 1994 |
Thermosensitive liposomal taxol formulation: heat-mediated targeted drug delivery in murine melanoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cholesterol; Combined Modality Therapy; Drug Carriers; Ethanol; Hot Temperature; Hyperthermia, Induced; Liposomes; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Paclitaxel; Phosphatidylcholines; Random Allocation; Survival Rate | 1998 |
A differential scanning calorimetry study of phosphocholines mixed with paclitaxel and its bromoacylated taxanes.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Acylation; Bridged-Ring Compounds; Calorimetry, Differential Scanning; Dimyristoylphosphatidylcholine; Lipid Bilayers; Paclitaxel; Phosphatidylcholines; Taxoids | 2000 |
Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cholesterol; Drug Carriers; Female; HT29 Cells; Humans; Liposomes; Macrophages; Mice; Mice, Inbred BALB C; Paclitaxel; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Succinimides; Tissue Distribution; Tumor Cells, Cultured | 2000 |
Vesicle-mediated phosphatidylcholine reapposition to the plasma membrane following hormone-induced phospholipase D activation.
Topics: Acrylamide; Androstadienes; Animals; Arginine Vasopressin; Brefeldin A; Cell Line; Cell Membrane; Cytochalasin B; Diphenylhexatriene; Enzyme Activation; Exocytosis; Fluorescent Dyes; Kinetics; Membrane Lipids; Muscle, Skeletal; Nocodazole; Paclitaxel; Phosphatidylcholines; Phospholipase D; Rats; Wortmannin; Zinc | 2000 |
Preparation and characterization of solid lipid nanospheres containing paclitaxel.
Topics: Antineoplastic Agents, Phytogenic; Chemistry, Pharmaceutical; Drug Carriers; Half-Life; Paclitaxel; Phosphatidylcholines; Triglycerides | 2000 |
MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping.
Topics: Adenosine Triphosphate; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Transporters; Biological Transport; Cell Polarity; Cells, Cultured; Cyclosporine; Cyclosporins; Cytotoxins; Daunorubicin; Digoxin; Epithelial Cells; Humans; Ivermectin; Kidney; Paclitaxel; Pharmaceutical Preparations; Phosphatidylcholines; Recombinant Proteins; Spodoptera; Swine; Verapamil; Vinblastine | 2000 |
Surface remodeling associated with vasopressin-induced membrane traffic in L6 myogenic cells.
Topics: Acridine Orange; Acrylamide; Androstadienes; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line; Cell Membrane; Cell Movement; Cytochalasin B; Enzyme Inhibitors; Exocytosis; Fluorescent Dyes; Fluorometry; Kinetics; Ligands; Microscopy, Electron; Microscopy, Electron, Scanning; Muscles; Paclitaxel; Phosphatidylcholines; Phosphatidylinositol 3-Kinases; Phospholipids; Phosphorylcholine; Rats; Signal Transduction; Time Factors; Vasopressins; Wortmannin | 2000 |
Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cell Division; Cell Membrane; Collagen; Doxorubicin; Drug Combinations; G2 Phase; Laminin; Methotrexate; Mitosis; Nocodazole; Nuclear Magnetic Resonance, Biomolecular; Paclitaxel; Phosphatidylcholines; Phospholipids; Phosphorus; Proteoglycans; Tumor Cells, Cultured; Vincristine | 2001 |
PEG-PE/phosphatidylcholine mixed immunomicelles specifically deliver encapsulated taxol to tumor cells of different origin and promote their efficient killing.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Cell Survival; Chromatography, High Pressure Liquid; Drug Carriers; Electrophoresis, Polyacrylamide Gel; Mice; Micelles; Nucleosomes; Paclitaxel; Particle Size; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Tumor Cells, Cultured | 2003 |
In vitro and in vivo characterization of a novel biocompatible polymer-lipid implant system for the sustained delivery of paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Biodegradation, Environmental; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Carriers; Drug Implants; Female; Humans; Linear Models; Mice; Mice, Inbred Strains; Paclitaxel; Phosphatidylcholines; Solubility | 2005 |
Hybrid films from blends of chitosan and egg phosphatidylcholine for localized delivery of paclitaxel.
Topics: Adsorption; Algorithms; Animals; Cell Line, Tumor; Cell Survival; Chitosan; CHO Cells; Cricetinae; Eggs; Excipients; Female; Humans; Lipids; Microspheres; Ovarian Neoplasms; Paclitaxel; Phosphatidylcholines; Spectroscopy, Fourier Transform Infrared | 2005 |
Paclitaxel-loaded lipid nanoparticles prepared by solvent injection or ultrasound emulsification.
Topics: Antineoplastic Agents, Phytogenic; Calorimetry, Differential Scanning; Emulsions; Esters; Fatty Acids; Nanoparticles; Paclitaxel; Particle Size; Phosphatidylcholines; Sucrose; Surface-Active Agents; Technology, Pharmaceutical; Ultrasonics | 2006 |
Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biocompatible Materials; Chitosan; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Carriers; Drug Implants; Eggs; Female; Glycerol; Humans; Injections, Intraperitoneal; Mice; Mice, Nude; Ovarian Neoplasms; Paclitaxel; Phosphatidylcholines; Xenograft Model Antitumor Assays | 2007 |
Liposome formulation of paclitaxel with enhanced solubility and stability.
Topics: Amines; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Cholesterol; Chromatography, High Pressure Liquid; Drug Screening Assays, Antitumor; Drug Stability; Drug Synergism; Freeze Drying; Humans; Hydrogen-Ion Concentration; Liposomes; Paclitaxel; Particle Size; Phosphatidylcholines; Polyethylene Glycols; Solubility; Static Electricity; Sucrose | 2007 |
Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Body Weight; Carbon Radioisotopes; Cell Line, Tumor; Cell Survival; Cholesterol; Cholesterol Esters; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Evaluation, Preclinical; Female; Humans; Inhibitory Concentration 50; Injections, Intraperitoneal; Lipoproteins, HDL; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Molecular Weight; Nanoparticles; Paclitaxel; Particle Size; Pharmaceutical Vehicles; Phosphatidylcholines; Weight Loss | 2008 |
Preparation and the in-vivo evaluation of paclitaxel liposomes for lung targeting delivery in dogs.
Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Cholesterol; Dogs; Drug Carriers; Drug Delivery Systems; Drug Stability; Drug Storage; Half-Life; Liposomes; Lung; Lung Neoplasms; Paclitaxel; Particle Size; Phosphatidylcholines; Polysorbates; Tissue Distribution; Ultrasonics | 2011 |
Efficacy and toxicological studies of cremophor EL free alternative paclitaxel formulation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Small Cell; Cell Line, Tumor; Deoxycholic Acid; Dose-Response Relationship, Drug; Excipients; Female; Glycerol; Glycine max; Humans; Lethal Dose 50; Liposomes; Lung Neoplasms; Male; Maximum Tolerated Dose; Mice; Paclitaxel; Phosphatidylcholines | 2011 |
Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorption.
Topics: Animals; Caco-2 Cells; Cell Membrane; Cell Survival; Diglycerides; Drug Carriers; Endocytosis; Humans; Male; Membrane Fluidity; Nanoparticles; Oxazines; Paclitaxel; Particle Size; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Solubility | 2012 |
Peptide ligand and PEG-mediated long-circulating liposome targeted to FGFR overexpressing tumor in vivo.
Topics: Animals; Antineoplastic Agents; Area Under Curve; Binding Sites; Cell Line, Tumor; Cholesterol; Drug Stability; Female; Humans; Ligands; Liposomes; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Paclitaxel; Peptides; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Random Allocation; Receptors, Fibroblast Growth Factor; Tissue Distribution | 2012 |
Salvage chemotherapy in recurrent platinum-resistant or refractory epithelial ovarian cancer with Carboplatin and distearoylphosphatidylcholine pegylated liposomal Doxorubicin (lipo-dox®).
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cystadenocarcinoma, Serous; Doxorubicin; Drug Resistance, Neoplasm; Endometrial Neoplasms; Fallopian Tube Neoplasms; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Phosphatidylcholines; Polyethylene Glycols; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate | 2013 |
Thermosensitive depot-forming injectable phosphatidylcholine blends tailored for localized drug delivery.
Topics: Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Delivery Systems; Injections; Paclitaxel; Phase Transition; Phosphatidylcholines; Porosity; Transition Temperature | 2013 |
Stable phosphatidylcholine-bile salt mixed micelles enhance oral absorption of paclitaxel: preparation and mechanism in rats.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Cell Line, Tumor; Drug Carriers; Drug Stability; Glycine max; Humans; Intestinal Absorption; Male; Micelles; Paclitaxel; Permeability; Phosphatidylcholines; Poloxamer; Polyethylene Glycols; Polyethyleneimine; Rats; Rats, Wistar; Sodium Cholate; Vitamin E | 2014 |
Paclitaxel-loaded stealth liposomes: Development, characterization, pharmacokinetics, and biodistribution.
Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Carcinoma; Cell Line, Tumor; Cholesterol; Drug Compounding; Drug Liberation; Half-Life; Humans; Injections, Intravenous; Liposomes; Liver; Lung Neoplasms; Mice; Paclitaxel; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Rats, Sprague-Dawley; Spleen; Tissue Distribution; Xenograft Model Antitumor Assays | 2016 |
The single-probe: a miniaturized multifunctional device for single cell mass spectrometry analysis.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Antineoplastic Agents; Cholestenones; Doxorubicin; HeLa Cells; Humans; Mass Spectrometry; Metabolome; Paclitaxel; Phosphatidylcholines; Saponins; Single-Cell Analysis | 2014 |
Molecular simulation of the concentration-dependent interaction of hydrophobic drugs with model cellular membranes.
Topics: Cell Membrane; Diffusion; Hydrophobic and Hydrophilic Interactions; Lipid Bilayers; Molecular Dynamics Simulation; Paclitaxel; Permeability; Phosphatidylcholines; Rotation; Water | 2014 |
Effects of triglycerides on the hydrophobic drug loading capacity of saturated phosphatidylcholine-based liposomes.
Topics: Antineoplastic Agents, Phytogenic; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Hydrophobic and Hydrophilic Interactions; Liposomes; Paclitaxel; Phase Transition; Phosphatidylcholines; Solubility; Structure-Activity Relationship; Triglycerides; Tumor Cells, Cultured | 2015 |
Release kinetics of paclitaxel and cisplatin from two and three layered gold nanoparticles.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Chemistry, Pharmaceutical; Cisplatin; Delayed-Action Preparations; Drug Liberation; Gold; Humans; Hydrophobic and Hydrophilic Interactions; Kinetics; Lipoproteins, HDL; Metal Nanoparticles; Models, Chemical; Paclitaxel; Phosphatidylcholines; Sulfhydryl Compounds | 2015 |
[Optimization of Formulation and Process of Paclitaxel PEGylated Liposomes by Box-Behnken Response Surface Methodology].
Topics: Chemistry, Pharmaceutical; Drug Liberation; Liposomes; Paclitaxel; Particle Size; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols | 2015 |
Ethanol-based proliposome delivery systems of paclitaxel for in vitro application against brain cancer cells.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Brain Neoplasms; Cell Line, Tumor; Cholesterol; Drug Liberation; Ethanol; Humans; Hydrogen-Ion Concentration; Hydrogenation; Liposomes; Paclitaxel; Particle Size; Phosphatidylcholines; Sonication; Surface Properties | 2018 |
Near-infrared mediated quantum dots and paclitaxel co-loaded nanostructured lipid carriers for cancer theragnostic.
Topics: Animals; Drug Carriers; Drug Delivery Systems; Emulsions; Female; Glycerides; Hep G2 Cells; Humans; Inhibitory Concentration 50; Lipids; Mice; Microscopy, Fluorescence; Nanostructures; Neoplasm Transplantation; Neoplasms; Oleic Acid; Optics and Photonics; Paclitaxel; Particle Size; Phosphatidylcholines; Quantum Dots; Spectroscopy, Near-Infrared; Temperature; Theranostic Nanomedicine | 2017 |
Development of Safe and Potent Oil-in-Water Emulsion of Paclitaxel to Treat Peritoneal Dissemination.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Ehrlich Tumor; Drug Liberation; Emulsions; Mice; Paclitaxel; Phosphatidylcholines; Polysorbates; Rats; Rats, Wistar; Swine; Treatment Outcome; Triglycerides | 2017 |
Cube-shaped theranostic paclitaxel prodrug nanocrystals with surface functionalization of SPC and MPEG-DSPE for imaging and chemotherapy.
Topics: Cell Survival; Fluorescence; Glycine max; HeLa Cells; Humans; Microscopy, Electron, Transmission; Nanoparticles; Nitro Compounds; Oxadiazoles; Paclitaxel; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Prodrugs; Spectroscopy, Fourier Transform Infrared; Theranostic Nanomedicine; X-Ray Diffraction | 2017 |
Roles of phospholipid methyltransferases in pycnidia development, stress tolerance and secondary metabolism in the taxol-producing fungus Pestalotiopsis microspore.
Topics: Amino Acid Sequence; Cell Wall; DNA, Fungal; Fungal Proteins; Gene Deletion; Gene Expression Profiling; Gene Expression Regulation, Fungal; Genes, Fungal; Hyphae; Paclitaxel; Phenotype; Phosphatidyl-N-Methylethanolamine N-Methyltransferase; Phosphatidylcholines; Phosphatidylethanolamines; Reproduction, Asexual; Secondary Metabolism; Sequence Alignment; Sequence Homology, Amino Acid; Spores, Fungal; Stress, Psychological; Xylariales | 2018 |
Liposils: An effective strategy for stabilizing Paclitaxel loaded liposomes by surface coating with silica.
Topics: Amines; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Cholesterol; Drug Liberation; Drug Stability; Erythrocytes; Hemolysis; Humans; Liposomes; Male; Melanoma, Experimental; Mice; Paclitaxel; Phosphatidylcholines; Rats, Sprague-Dawley; Silicon Dioxide | 2018 |
An organic solvent-free technology for the fabrication of albumin-based paclitaxel nanoparticles for effective cancer therapy.
Topics: Albumins; Allografts; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Female; Humans; Hydrogen-Ion Concentration; Liposomes; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Nanoparticles; Paclitaxel; Particle Size; Phosphatidylcholines; Rats, Sprague-Dawley; Serum Albumin, Bovine; Tumor Burden | 2019 |
Targeted Delivery of Combination Therapeutics Using Monoclonal Antibody 2C5-Modified Immunoliposomes for Cancer Therapy.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Membrane Permeability; Cell Proliferation; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Liberation; Female; Humans; Liposomes; Mice, Nude; Neoplasms, Experimental; Paclitaxel; Phosphatidylcholines; Polyethylene Glycols; Pyrans | 2021 |
Paclitaxel loading in cationic liposome vectors is enhanced by replacement of oleoyl with linoleoyl tails with distinct lipid shapes.
Topics: Antineoplastic Agents; Fatty Acids, Monounsaturated; Humans; Linoleic Acids; Liposomes; Oleic Acid; Paclitaxel; PC-3 Cells; Phosphatidylcholines; Quaternary Ammonium Compounds | 2021 |
Phase Behavior of Pure PSPC and PEGylated Multicomponent Lipid and Their Interaction with Paclitaxel: An All-Atom MD Study.
Topics: Lipid Bilayers; Paclitaxel; Phase Transition; Phosphatidylcholines; Phosphorylcholine; Polyethylene Glycols | 2021 |